A survey of patient and physician acceptance of skin toxicities from anti-epidermal growth factor receptor therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A survey of patient and physician acceptance of skin toxicities from anti-epidermal growth factor receptor therapies

Published:2017-11-07 Issue:4 Volume:26 Page:1169-1179
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Tischer Bernd,Bilang Martina,Kraemer Matthias,Ronga Philippe,Lacouture Mario E.

Funder

Merck KGaA, Darmstadt, Germany

NIH/NCI Cancer Center Support Grant

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/article/10.1007/s00520-017-3938-7/fulltext.html

Reference30 articles.

1. Van Cutsem E, Kohne CH, Hitre E et al (2009) Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 360(14):1408–1417

2. Bonner JA, Harari PM, Giralt J et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354(6):567–578

3. Pirker R, Pereira JR, Szczesna A et al (2009) Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial. Lancet 373(9674):1525–1531

4. Lacouture ME, Keefe DM, Sonis S et al (2016) A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer. Ann Oncol 27(9):1712–1718

5. Moore MJ, Goldstein D, Hamm J et al (2007) Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25(15):1960–1966

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Value of Teledermatology Advice for Skin Toxicity in Oncology: Experience From a Pilot Study;JMIR Dermatology;2024-02-29

2. The Impact of Dermatologic Adverse Events on the Quality of Life of Oncology Patients: A Review of the Literature;American Journal of Clinical Dermatology;2024-02-16

3. Quality of Life Impact in Patients with Cutaneous Toxicities Caused by Epidermal Growth Factor Receptor Inhibitors and Immunotherapy;Dermatology;2024

4. Reaffirming Adverse Events Related to Lung Cancer Survivors’ Target Therapies and Their Apparent Effects on Fear of Cancer Progression, Anxiety, and Depression;Cancer Nursing;2022-12-01

5. Looking into the toxicity potential and clinical benefits of tyrosine kinase inhibitors (TKIs);Reference Module in Biomedical Sciences;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3